Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 5/20 | 0.40 |
| ▸ | ANPEP | P15144 | 5/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13698771 | 0.79 | GABRA1 (0.41) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL28716736 | 0.77 | GABRA1 (0.40) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL29501774 | 0.77 | GABRA1 (0.40) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL20033362 | 0.77 | GABRA1 (0.40) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL1683077 | 0.77 | GABRA1 (0.40) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL20408262 | 0.76 | GABRA1 (0.39) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL18649131 | 0.74 | GABRA1 (0.38) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL18736500 | 0.74 | GABRA1 (0.38) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL2231810 | 0.74 | GABRA1 (0.38) | DPP4ANPEPGABRA1GABRG2GABRB3 | |
| SCHEMBL18412477 | 0.74 | GABRA1 (0.38) | DPP4ANPEPGABRA1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10682636-B2 | Immobilized ruthenium-triphos catalysts for selective hydrogenolysis of amides | EASTMAN CHEMICAL COMPANY (US) | 2020-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10682636-B2 | Immobilized ruthenium-triphos catalysts for selective hydrogenolysis of amides | ADH5, ADH1A, ADH1C | DPP4 4005/4885ANPEP 2034/4885GABRA1 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.